We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hemoglobin Assay Performed with Photothermal Optical Sensor

By LabMedica International staff writers
Posted on 11 Jan 2015
An optical sensor, termed a photothermal spectral-domain optical coherence reflectometer (PT SD-OCR) is capable of direct measurement of hemoglobin concentration (Hb) without chemicals and preprocessing of blood.

The PT SD-OCR OCR measures Hb by quantifying refractive index changes of blood samples due to photothermal effect under the irradiation of 532-nm light and its diagnostic accuracy and precision has been evaluated in anemic patients.

Scientists at the Yonsei University (Seoul, Republic of Korea) and their colleagues used PT SD-OCR to measure Hb in 50 anemic patients, and examined its accuracy against a hematology analyzer. More...
Its precision was assessed by examining the standard deviation (SD) and coefficients of variation (CV) based on 20 repeated measurements on three blood sample and its performance was also compared with a hemoglobinometer.

The relative accuracy of the PT SD-OCR sensor was examined and the comparisons of the PT SD-OCR and HemoCue 201+ System (Angelholm, Sweden) against the results from the ADVIA 2120i hematology analyze (Siemens AG, Erlangen, Germany). An excellent correlation was observed between the results from the hematology analyzer and those of the PT SD-OCR sensor. The precision of the PT SD-OCR sensor was also comparable with the ADVIA 2120i analyzer and the HemoCue 201+ detector.

The authors concluded that simple and chemical-free operation of PT SD-OCR enabled rapid and accurate measurement of Hb in anemic patients. The sensor is expected to facilitate clinical procedures related to blood-related disorders in patient care. The PT SD-OCR sensor may therefore be readily utilized in clinical settings for hemoglobin detection and determination of proper treatment strategies for anemic patients. The study was published in the January 2015 issue of the journal Clinica Chimica Acta.

Related Links:

Yonsei University
HemoCue
Siemens AG 



New
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.